Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing

Biogen in Podcasts

company

Biogen is a biotech company that partnered to develop an SMA drug, as mentioned by Dhinakar Singh.

Mentions Over Time

5 mentions
1 related entities

Discussed alongside in this corpus

Audioscrape has indexed podcast episodes that discuss Biogen together with the following entities. Each link opens the other entity's page; hover over the contextual tag for the most common relationship our index has captured.

Mentions in Podcasts

The Claire Byrne Show
Could medicine soon be made available for those suffering from Friedrich’s Ataxia? 

Look, Biogen did send it into the HSE on the 21st of May.

The Claire Byrne Show
The pressure is on for life-changing medicine for Friedrich’s Ataxia to be available.

And Biogen has submitted that further information.

Liveline
"Time is not on our side"

between the pharmaceutical company, Biogen, and the HSE.

Bloomberg News Now
Taiwan Emerges as Top Risk to Ties, Retail Sales Rise, More

Biogen saying it will advance its experimental Alzheimer's drug after getting promising though inconclusive signs of benefit in a mid-stage study.

Invest Like the Best with Patrick O'Shaughnessy
Dinakar Singh - A Father’s Call To Action - [Invest Like the Best, EP.428]

So Biogen essentially bought in the drug and became the first to market with an SMA drug.